European Medicines Agency recommends measures to manage contamination of heparin-containing medicine
- Details
- Category: Research
![The European Medicines Agency The European Medicines Agency](http://www.worldpharmanews.com/images/stories/logo/emea.gif)
New Efforts to Help Improve Medical Products for Patient Safety and Quality of Medical Care
- Details
- Category: Research
![U.S. Food and Drug Administration (FDA) U.S. Food and Drug Administration (FDA)](http://www.worldpharmanews.com/images/stories/logo/fda.gif)
Carbon nanotubes may cause cancer, study reveals
- Details
- Category: Research
A new study conducted by a team of UK and US scientists has revealed the carcinogenic potential of certain carbon nanotubes. In a paper published in Nature Nanotechnology on 20 May, the researchers describe asbestos-like features in long, multi-walled carbon nanotubes (MWCNTs), when they are inhaled in sufficient quantities.
UK parliament backs hybrid embryo research
- Details
- Category: Research
The UK Parliament has voted to allow the creation of embryos containing both human and animal genetic material for research purposes. As apart of a two-date debate on amendments to the Human Fertilisation and Embryology Bill, members of parliament voted 342 to 163 against an amendment to outlaw so-called hybrid or admixed embryos.
New Light on the Way Blood Vessels Grow
- Details
- Category: Research
New research conducted by a group of EU-funded researchers is shedding new light on the way blood vessels grow, overturning years of medical thought. The findings have important implications for the development of novel drugs to treat diseases such as cancer, many of which target the tumour's ability to grow its own blood vessels.
Scientists identify molecule behind fat deposition and insulin release
- Details
- Category: Research
Scientists at the Karolinska Institute in Sweden have identified a molecule which plays a key role in both the regulation of body fat and the release of insulin from the pancreas. Two papers presenting the results are published online by the journal the Proceedings of the National Academy of Sciences (PNAS).
Scientists solve mystery of why arsenic works in cancer drugs
- Details
- Category: Research
Since the 18th century, several arsenic compounds have been used as medicines, including arsenic trioxide (ATO) which is commonly prescribed in the treatment of certain types of cancer. Although they prove to be effective, no one knows how these compounds work.
More Pharma News ...
- Innovative Medicines Initiative to give boost to Europe's pharmaceutical industry
- Survey Takes Pulse of eHealth in Europe and Prescribes Wider ICT use Among Doctors
- Ozmosis and the Doctor's Channel Revolutionize Online Medical Knowledge Exchange with Video Content
- New Drug Reference Application to Enable Access to Multilex DDF on the Move
- New DNA sequencing strategy could be vital during disease outbreak
- Latest Internet Technology for the Replacement of Animal Experiments
- New light on how a mutation in a protein causes acute myeloid leukaemia